Drugs industry supplier Lonza LONN.VX gains 6 percent, far outpacing healthcare rivals .SXDP with traders citing talk of a potential takeover with the shares looking cheap after recent falls.
“The market talk is that EMS Chemie EMSN.VX could be interested in a stake,” one trader says.
Lonza declines to comment and EMS is not immediately available to comment.
Shares in Swiss specialty chemicals group EMS are flat.
Reuters Messaging rm://email@example.com